A citation-based method for searching scientific literature

O Zhuchenko, J Bailey, P Bonnen, T Ashizawa, D W Stockton, C Amos, W B Dobyns, S H Subramony, H Y Zoghbi, C C Lee. Nat Genet 1997
Times Cited: 978

I A Klement, P J Skinner, M D Kaytor, H Yi, S M Hersch, H B Clark, H Y Zoghbi, H T Orr. Cell 1998
Times Cited: 686

List of shared articles

Times cited

Pathogenic mechanisms underlying spinocerebellar ataxia type 1.
Leon Tejwani, Janghoo Lim. Cell Mol Life Sci 2020

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion.
Anna Niewiadomska-Cimicka, Antoine Hache, Yvon Trottier. Front Neurosci 2020

Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.
Swati Naphade, Kizito-Tshitoko Tshilenge, Lisa M Ellerby. Neurotherapeutics 2019

From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
Maria Pennuto, Carlo Rinaldi. Mol Cell Endocrinol 2018

Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3.
Zi-Jian Wang, Aoife Hanet, Daniel Weishäupl, Inês M Martins, Anna S Sowa, Olaf Riess, Thorsten Schmidt. CNS Neurosci Ther 2018

Deregulation of RNA Metabolism in Microsatellite Expansion Diseases.
Chaitali Misra, Feikai Lin, Auinash Kalsotra. Adv Neurobiol 2018

Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer.
Andrea E Murmann, Jindan Yu, Puneet Opal, Marcus E Peter. Trends Cancer 2018

Keeping Our Calcium in Balance to Maintain Our Balance.
Melanie D Mark, Jan Claudius Schwitalla, Michelle Groemmke, Stefan Herlitze. Biochem Biophys Res Commun 2017

Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.
Sofia Esteves, Sara Duarte-Silva, Patrícia Maciel. Med Res Rev 2017